Patents by Inventor Vladimir Potapov

Vladimir Potapov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11713484
    Abstract: Providing herein, among other things, is a method comprising incubating a double-stranded nucleic acid having a nick with a nick translating activity, a ligase, and a nucleotide mix comprising at least one modified nucleotide, to generate a product comprising a patch of a newly synthesized strand of a duplex nucleic acid containing a plurality of modified nucleoside monophosphates that are at or adjacent to the site of the nick. In some embodiments, the method may be used to map damaged nucleoside monophosphates in a nucleic acid. Compositions and kits for use in performing the method are also provided.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: August 1, 2023
    Inventors: Kelly M. Zatopek, Vladimir Potapov, Jennifer Ong, Laurence Ettwiller, Lixin Chen, Thomas C. Evans, Jr., Andrew F. Gardner
  • Publication number: 20220380741
    Abstract: The present disclosure relates, according to some embodiments, to systems, apparatus, compositions, methods, and workflows that include DNase I variants with desirable properties including, for example, salt tolerance. A DNase I variant, in some embodiments, may have an amino acid sequence that is at least 85% identical, at least 90% identical, at least 95% identical, and/or at least 98% identical to SEQ ID NO:1 and may be identical to SEQ ID NO:1 at one or more positions selected from the group of positions corresponding to L29, A35, D87, Q88, S94, P103, T108, P121, P132, A135, D145, E161, G172, P190, H208, and A224 of SEQ ID NO:1.
    Type: Application
    Filed: May 27, 2021
    Publication date: December 1, 2022
    Applicant: New England Biolabs, Inc.
    Inventors: Heidi Crosby, Jennifer Ong, Ashley Luck, Eric J. Cantor, Vladimir Potapov
  • Publication number: 20220380738
    Abstract: The present disclosure relates, according to some embodiments, to compositions, methods, systems, and kits for programmable endonucleolytic cleavage of DNA (e.g., ds DNA). For example, the in vitro activity of an Argonaute (e.g., a mesophilic Argonaute CbAgo from Clostridium butyricum) may be synchronized with DNA strand unwinding activity of a helicase (e.g., a nuclease deficient RecBexo-C DNA helicase from E. coli) for a rapid and efficient cleavage of double-stranded DNA targets. Enzymatic properties of CbAgo and different aspects of ds DNA cleavage were thoroughly explored by adapting high-throughput capillary electrophoreses technique for monitoring CbAgo cleavage activity in concurrence with RecBexo-C. The present disclosure shows that in the presence of RecBexo-C, CbAgo can be programmed with guides to cleave any site of interest localized at up to 10 kb distance from the end of linear ds DNA at 37° C. temperature.
    Type: Application
    Filed: June 1, 2021
    Publication date: December 1, 2022
    Applicant: New England Biolabs, Inc.
    Inventors: Jurate Bitinaite, Rita Vaiskunaite, Vladimir Potapov, Nathan Tanner
  • Publication number: 20220275352
    Abstract: A bacteriophage RNA polymerase variant is provided. In some embodiments, the variant may have increased thermostability relative to the corresponding wild type bacteriophage RNA polymerase and/or wild type T7 RNA polymerase. Compositions, kits and methods that employ the variant are also provided.
    Type: Application
    Filed: May 11, 2022
    Publication date: September 1, 2022
    Applicant: New England Biolabs, Inc.
    Inventors: Jennifer Ong, Vladimir Potapov, Kuo-Chan Hung, Haruichi Asahara, Shaorong Chong, George Tzertzinis
  • Patent number: 11371028
    Abstract: Variants of the bacteriophage B103 DNA polymerase are described herein. The variant has improved properties, that include when compared to wild-type Phi29 DNA polymerase, at least one of the following: increased thermostability, improved reaction rate for DNA amplification, reduced background and a reduction of bias. Methods of using the DNA polymerase variant are also described herein.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: June 28, 2022
    Assignee: New England Biolabs, Inc.
    Inventors: Jennifer Ong, Nathan Tanner, Yinhua Zhang, Yanxia Bei, Vladimir Potapov
  • Patent number: 11359184
    Abstract: A bacteriophage RNA polymerase variant is provided. In some embodiments, the variant may have increased thermostability relative to the corresponding wild type bacteriophage RNA polymerase and/or wild type T7 RNA polymerase. Compositions, kits and methods that employ the variant are also provided.
    Type: Grant
    Filed: November 11, 2019
    Date of Patent: June 14, 2022
    Assignee: New England Biolabs, Inc.
    Inventors: Jennifer Ong, Vladimir Potapov, Kuo-Chan Hung, Haruichi Asahara, Shaorong Chong, George Tzertzinis
  • Publication number: 20220177875
    Abstract: Ordered assembly of large numbers of fragments into a single large DNA have been improved in both frequency and fidelity of the assembled product. This has been achieved by novel compositions and methods that are utilized in a computer system that integrates comprehensive ligation data from multiple sources to provide optimized synthetic overhangs or overhangs from restriction endonuclease cleavage on DNA fragments for assembly by ligation. Intragenic cut sites are avoided by the use of a novel restriction endonuclease which recognizes 7 nucleotides (bases) and cuts DNA to create 4-base overhangs with the help of a synthetic activator oligonucleotide. Variations in ligation preferences by different ligases provide extra precision in assembly reactions. The use of the improved methods are exemplified by the successful assembly from 52 fragments of a viral genome and also a 52 fragment ordered assembly of a bacteria operon.
    Type: Application
    Filed: December 17, 2021
    Publication date: June 9, 2022
    Applicant: New England Biolabs, Inc.
    Inventors: Gregory Lohman, Vladimir Potapov, John M. Pryor, Rebecca Kucera, Katharina Bilotti, Richard D. Morgan
  • Publication number: 20220098577
    Abstract: A composition and its uses and additionally a kit are provided. The composition is a synthetic self-complementary oligonucleotide that has a double-stranded region and a loop, wherein the double-stranded region contains a binding sequence for PaqCl. Additionally, the oligonucleotide includes unligatable 3? and 5? ends that cannot be cleaved by PaqCl. This oligonucleotide composition has been combined with PaqCl or a variant of PaqCl Type IIS restriction endonuclease in a reaction mixture, where the reaction mixture includes PaqCl or variant that can further be combined with a ligase and optionally a deadenylase, crowding molecule such as PEG and/or a repair enzyme such as Endo MS. The kit includes the oligonucleotide and Type IIS restriction endonuclease in the same or different containers.
    Type: Application
    Filed: December 15, 2021
    Publication date: March 31, 2022
    Applicant: New England Biolabs, Inc.
    Inventors: Gregory Lohman, John M. Pryor, Rebecca Kucera, Vladimir Potapov, Katharina Bilotti, Richard D. Morgan
  • Publication number: 20210383891
    Abstract: Methods and compositions are provided for optimizing ordered assembly of a plurality of polynucleotide fragments. The optimization involves providing sets of overhang sequences with preferred experimental conditions for high fidelity ordered assembly of polynucleotide fragments by ligation under selected experimental conditions. The methods and compositions provide the use of a computer system with inputs having a plurality of menus and outputs that include a variety of media interfaces. The computer system has access to a ligation frequency database to provide sets of overhang sequences for efficient joining of multiple fragments into the target nucleic acid.
    Type: Application
    Filed: October 17, 2019
    Publication date: December 9, 2021
    Applicant: New England Biolabs, Inc.
    Inventors: Gregory Lohman, Vladimir Potapov, John M. Pryor, Rebecca Kucera
  • Publication number: 20210155909
    Abstract: Variants of the bacteriophage B103 DNA polymerase are described herein. The variant has improved properties, that include when compared to wild-type Phi29 DNA polymerase, at least one of the following: increased thermostability, improved reaction rate for DNA amplification, reduced background and a reduction of bias. Methods of using the DNA polymerase variant are also described herein.
    Type: Application
    Filed: January 25, 2021
    Publication date: May 27, 2021
    Applicant: New England Biolabs, Inc.
    Inventors: Jennifer Ong, Nathan Tanner, Yinhua Zhang, Yanxia Bei, Vladimir Potapov
  • Patent number: 10934533
    Abstract: Variants of the bacteriophage B103 DNA polymerase are described herein. The variant has improved properties, that include when compared to wild-type Phi29 DNA polymerase, at least one of the following: increased thermostability, improved reaction rate for DNA amplification, reduced background and a reduction of bias. Methods of using the DNA polymerase variant are also described herein.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: March 2, 2021
    Assignee: New England Biolabs, Inc.
    Inventors: Jennifer Ong, Nathan Tanner, Yinhua Zhang, Yanxia Bei, Vladimir Potapov
  • Patent number: 10837009
    Abstract: Mutant bacteriophage DNA ligases that have increased tolerance to salt and/or heat is provided. Methods, compositions and kits that employ the same are also provided.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: November 17, 2020
    Assignee: New England Biolabs, Inc.
    Inventors: Jennifer Ong, Gregory Lohman, Aine Quimby, Vladimir Potapov, John M. Pryor
  • Publication number: 20200325533
    Abstract: Providing herein, among other things, is a method comprising incubating a double-stranded nucleic acid having a nick with a nick translating activity, a ligase, and a nucleotide mix comprising at least one modified nucleotide, to generate a product comprising a patch of a newly synthesized strand of a duplex nucleic acid containing a plurality of modified nucleoside monophosphates that are at or adjacent to the site of the nick. In some embodiments, the method may be used to map damaged nucleoside monophosphates in a nucleic acid. Compositions and kits for use in performing the method are also provided.
    Type: Application
    Filed: August 21, 2018
    Publication date: October 15, 2020
    Applicant: New England Biolabs, Inc.
    Inventors: Kelly M. Zatopek, Vladimir Potapov, Jennifer Ong, Laurence Ettwiller, Lixin Chen, Thomas C. Evans, Jr., Andrew F. Gardner
  • Publication number: 20200123513
    Abstract: A bacteriophage RNA polymerase variant is provided. In some embodiments, the variant may have increased thermostability relative to the corresponding wild type bacteriophage RNA polymerase and/or wild type T7 RNA polymerase. Compositions, kits and methods that employ the variant are also provided.
    Type: Application
    Filed: November 11, 2019
    Publication date: April 23, 2020
    Applicant: New England Biolabs, Inc.
    Inventors: Jennifer Ong, Vladimir Potapov, Kuo-Chan Hung, Haruichi Asahara, Shaorong Chong, George Tzertzinis
  • Patent number: 10519431
    Abstract: A bacteriophage RNA polymerase variant is provided. In some embodiments, the variant may have increased thermostability relative to the corresponding wild type bacteriophage RNA polymerase and/or wild type T7 RNA polymerase. Compositions, kits and methods that employ the variant are also provided.
    Type: Grant
    Filed: May 12, 2017
    Date of Patent: December 31, 2019
    Assignee: New England Biolabs, Inc.
    Inventors: Jennifer Ong, Vladimir Potapov, Kuo-Chan Hung, Haruichi Asahara, Shaorong Chong, George Tzertzinis
  • Publication number: 20190024061
    Abstract: A bacteriophage RNA polymerase variant is provided. In some embodiments, the variant may have increased thermostability relative to the corresponding wild type bacteriophage RNA polymerase and/or wild type T7 RNA polymerase. Compositions, kits and methods that employ the variant are also provided.
    Type: Application
    Filed: January 12, 2017
    Publication date: January 24, 2019
    Applicant: New England Biolabs, Inc.
    Inventors: Jennifer Ong, Shaorong Chong, Haruichi Asahara, Kuo-Chan Hung, Vladimir Potapov, George Tzertzinis
  • Publication number: 20170247670
    Abstract: A bacteriophage RNA polymerase variant is provided. In some embodiments, the variant may have increased thermostability relative to the corresponding wild type bacteriophage RNA polymerase and/or wild type T7 RNA polymerase. Compositions, kits and methods that employ the variant are also provided.
    Type: Application
    Filed: May 12, 2017
    Publication date: August 31, 2017
    Applicant: New England Biolabs, Inc.
    Inventors: Jennifer Ong, Vladimir Potapov, Kuo-Chan Hung, Haruichi Asahara, Shaorong Chong, George Tzertzinis
  • Patent number: 8416864
    Abstract: A method and modem are provided for obtaining an optimized efficiency of an Orthogonal Frequency Division Multiplex (OFDM) data transmission, such as for power line communication, for example. The length or duration of a guard interval or cyclic prefix in an OFDM symbol is newly selected at each start-up of a modem while initializing or preparing the OFDM data transmission. The length of the guard interval can be given by the number of samples in a time-discrete representation, and the value of such number of samples that is retained for the subsequent data transmission can be selected from a plurality of pre-determined possibilities based on an evaluation of a channel quality of a communication channel including a physical line to which the modem is connected. Hence, the selected value depends on actual transmission conditions, and the optimization potential offered by a more flexible handling of system parameters is exploited to meet changing conditions on the physical line.
    Type: Grant
    Filed: June 29, 2009
    Date of Patent: April 9, 2013
    Inventors: Dmitri Korobkov, Patrick Langfeld, Vladimir Potapov, Christian Leeb, Hans-Joerg Maag, Hans Benninger, Stefan Ramseier
  • Publication number: 20100054314
    Abstract: A method and modem are provided for obtaining an optimized efficiency of an Orthogonal Frequency Division Multiplex (OFDM) data transmission, such as for power line communication, for example. The length or duration of a guard interval or cyclic prefix in an OFDM symbol is newly selected at each start-up of a modem while initializing or preparing the OFDM data transmission. The length of the guard interval can be given by the number of samples in a time-discrete representation, and the value of such number of samples that is retained for the subsequent data transmission can be selected from a plurality of pre-determined possibilities based on an evaluation of a channel quality of a communication channel including a physical line to which the modem is connected. Hence, the selected value depends on actual transmission conditions, and the optimization potential offered by a more flexible handling of system parameters is exploited to meet changing conditions on the physical line.
    Type: Application
    Filed: June 29, 2009
    Publication date: March 4, 2010
    Applicant: ABB TECHNOLOGY AG
    Inventors: Dmitri Korobkov, Patrick Langfeld, Vladimir Potapov, Christian Leeb, Hans-Joerg Maag, Hans Benninger, Stefan Ramseier